Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-06-14

Clinical Trial Update: Safety Study of Infant Formula With Partially Hydrolized Whey [NA]

View source ↗

Summary

A clinical trial evaluating the safety of infant formula with partially hydrolyzed whey sponsored by Soroka University Medical Center was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infant formula with partially hydrolyzed whey

Snippet

Sponsor: Soroka University Medical Center | Conditions: Growth Failure | NA | Status: WITHDRAWN